PWMG
CTKB icon

Private Wealth Management Group’s Cytek Biosciences CTKB Stock Holding History

Private Wealth Management Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.1K Hold
1,694
– – ﹤0.01% 626
2026
Q2 		$7.5K Hold
1,694
– – ﹤0.01% 676
2026
Q1 		$7.4K Hold
1,694
– – ﹤0.01% 625
2025
Q4 		$8.56K Hold
1,694
– – ﹤0.01% 560
2025
Q3 		$5.88K Hold
1,694
– – ﹤0.01% 730
2025
Q2 		$5.76K Buy
+1,694
New +$5.64K ﹤0.01% 694

Other funds holding CTKB

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Private Wealth Management Group's CTKB Position: Q3 2026 in Review

Private Wealth Management Group held its Cytek Biosciences (CTKB) position steady in Q3 2026 at 1,694 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Private Wealth Management Group first reported a position in CTKB in Q2 2025 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Private Wealth Management Group held 1,694 shares of Cytek Biosciences worth $10.1K as of Q3 2026.
  • Private Wealth Management Group left its Cytek Biosciences share count unchanged in Q3 2026.
  • Cytek Biosciences made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #626 holding.
  • Private Wealth Management Group first reported a position in Cytek Biosciences in Q2 2025 and has held it in 6 quarters since.
  • 18 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.